0000-0002-2714-5352 About
I did Ph.D. in Immunology and Virology and now working in the area of Vaccine development for low and middle income countries at Vaccine Analytics and Formulation Centre, University of Kansas, Kansas. My expertise is developing vaccine formulations, excipient screening, in vitro assay development, real time and accelerated stability studies.
Employment
-
University of Kansas Post doctoral researcher2019 - Present
Education
-
Amity University Ph.D.2015 - 2019
Projects & Funding
Projects & funding information is unavailable.
Publications (7)
- PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse immunogenicity studies Save
- A Combined LC-MS and Immunoassay Approach to Characterize Preservative-Induced Destabilization of Human Papillomavirus Virus-like Particles Adsorbed to an Aluminum-Salt Adjuvant Save
- Multi-Dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part I - Screening of Preservative Combinations Save
- Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real-time and Accelerated Stability Studies Save
- Analytical and Preformulation Characterization Studies of Human Papillomavirus Virus-Like Particles to Enable Quadrivalent Multi-Dose Vaccine Formulation Development Save
- Inhibition ELISA as a putative tool for the identification and quantification of meningococcal A and X polysaccharides at various stages of vaccine development Save
- Evaluation of impact of temperature and pH alterations on the size and antigenicity of meningococcal serogroup A and X polysaccharides and conjugates Save